Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 May 9;23(8):1521–1528. doi: 10.1158/1055-9965.EPI-13-1176

Table 4. Comparison of hypothetical strategy of non-tailored access and navigation for both FIT and CX versus TNI strategy of tailored access and navigation for preferred test(s) only (N = 933*).

Overall screening FIT screening vs. none CX screening vs. none
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Among those with:
 FIT preference 1.12 (0.47, 2.66) 0.799 0.95 (0.36, 2.51) 0.918 5.39 (0.57, 51.2) 0.143
 Equal FIT/CX preference 1.00 N/A 1.00 N/A 1.00 N/A
 CX preference 2.70 (1.36, 5.37) 0.005 5.62 (1.81, 17.4) 0.001 1.78 (0.75, 4.20) 0.190
*

Final multivariable results based on 933 participants with full covariate data. The model included terms for preference, access, and navigation (from which the above tailoring effects were estimated), and controlled for primary care practice, age, sex, race, education, marital status, perceptions of CRC and screening, and baseline screening decision stage.

FIT: fecal immunochemical test. CX: colonoscopy.

N/A: not applicable (interventions are identical by design for this preference group).